KYSLECEL™ (autologous pancreatic islets)
Company

KYSLECEL™ (autologous pancreatic islets)

Biotechnology Research New Albany, Indiana, United States 2 employees
Employees
2
Contacts
1
Emails
1

KYSLECEL™ (autologous pancreatic islets) Overview

Headquarters
New Albany, Indiana, United States
Website
koligo.net
Industry
Biotechnology Research
Employees
2
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About KYSLECEL™ (autologous pancreatic islets)

KYSLECEL™ (autologous pancreatic islets) is a transformative cell therapy for pancreatic diseases. The process includes a total pancreatectomy (removal of the pancreas) with islet auto-transplantation (TP-IAT). This can provide significant pain relief with long-term glycemic control. Kyslecel is made from your own pancreatic islets – the cells that produce insulin in your pancreas. Your surgeon removes the diseased pancreas (source of pain and inflammation), we transport the organ from the operating room to our laboratory, and where we preserve your islets to make Kyslecel. Kyslecel is available in the U.S. for the treatment of chronic or acute recurrent pancreatitis after total pancreatectomy. To learn more visit: www.kyslecel.com

KYSLECEL™ (autologous pancreatic islets) Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

KYSLECEL™ (autologous pancreatic islets) Org Chart

Sample employees and titles
Name Title Contact
William Tucker Laboratory Director at Koligo
Email

Compare Similar Companies to KYSLECEL™ (autologous pancreatic islets)